In fact, mutant-p53 was shown to diminish glutathione synthesis via supressing an important GSH-ROS system’s controller gene namely SLC7A11, rendering mutant-p53 tumours susceptible to oxidative damage [33,34]. The gene discussed is TP53; the disease is neoplasm.